artenimol has been researched along with Melanoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baratto, MC; Bizzarri, BM; Botta, L; Cesarini, S; Filippi, S; Pogni, R; Saladino, R; Zippilli, C | 1 |
| Azimian, S; Bair, WB; Cabello, CM; Lamore, SD; Lesson, JL; Qiao, S; Wondrak, GT | 1 |
2 other study(ies) available for artenimol and Melanoma
| Article | Year |
|---|---|
Stereoselective Access to Antimelanoma Agents by Hybridization and Dimerization of Dihydroartemisinin and Artesunic acid.
Topics: Antineoplastic Agents; Artemisinins; Cell Proliferation; Cell Survival; Cells, Cultured; Dimerization; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Melanoma; Molecular Structure; Stereoisomerism; Structure-Activity Relationship; Succinates | 2021 |
The redox antimalarial dihydroartemisinin targets human metastatic melanoma cells but not primary melanocytes with induction of NOXA-dependent apoptosis.
Topics: Antimalarials; Antioxidants; Apoptosis; Artemisinins; Caspase 3; Cells, Cultured; Cytoprotection; DNA Damage; Drug Screening Assays, Antitumor; Enzyme Activation; Epidermis; Gene Expression Regulation, Neoplastic; Genome, Human; Humans; Iron Chelating Agents; Melanocytes; Melanoma; Mitochondria; Neoplasm Metastasis; Oligonucleotide Array Sequence Analysis; Oxidation-Reduction; Oxidative Stress; Phosphorylation; Proto-Oncogene Proteins c-bcl-2; Tumor Suppressor Protein p53; Up-Regulation | 2012 |